Athena Drug Patent Portfolio
Athena owns 3 orange book drugs protected by 8 US patents Given below is the list of Athena's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103452 | Tramadol hydrochloride solution | 01 Sep, 2040 | Active |
| US11752103 | Tramadol hydrochloride solution | 01 Sep, 2040 | Active |
| US8623409 | Clonidine formulation | 08 Sep, 2031 | Active |
| US7569612 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7741373 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7741374 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7915247 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US8337890 | Modified release formulations containing drug-ion exchange resin complexes | 17 Apr, 2027 | Active |
Latest Legal Activities on Athena's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Athena.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 May, 2024 | US8337890 |
| Mail Patent eGrant Notification | 12 Sep, 2023 | US11752103 |
| Patent eGrant Notification | 12 Sep, 2023 | US11752103 |
| Recordation of Patent eGrant | 12 Sep, 2023 | US11752103 |
|
Email Notification
Critical
| 12 Sep, 2023 | US11752103 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Sep, 2023 | US11752103 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Sep, 2023 | US11752103 |
|
Email Notification
Critical
| 24 Aug, 2023 | US11752103 |
|
Issue Notification Mailed
Critical
| 23 Aug, 2023 | US11752103 |
| Dispatch to FDC | 10 Aug, 2023 | US11752103 |
|
Application Is Considered Ready for Issue
Critical
| 10 Aug, 2023 | US11752103 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 28 Jul, 2023 | US11752103 |
|
Response to Amendment under Rule 312
Critical
| 26 Jul, 2023 | US11752103 |
|
Issue Fee Payment Verified
Critical
| 10 Jul, 2023 | US11752103 |
|
Issue Fee Payment Received
Critical
| 10 Jul, 2023 | US11752103 |
Athena's Family Patents
Athena Drug List
Given below is the complete list of Athena's drugs and the patents protecting them.
1. Fibricor
Fibricor is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7569612 | Methods of use of fenofibric acid |
20 Aug, 2027
(2 years from now)
| Active |
| US7741373 | Methods of use of fenofibric acid |
20 Aug, 2027
(2 years from now)
| Active |
| US7741374 | Methods of use of fenofibric acid |
20 Aug, 2027
(2 years from now)
| Active |
| US7915247 | Methods of use of fenofibric acid |
20 Aug, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fibricor's drug page
2. Nexiclon Xr
Nexiclon Xr is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8623409 | Clonidine formulation |
08 Sep, 2031
(6 years from now)
| Active |
| US8337890 | Modified release formulations containing drug-ion exchange resin complexes |
17 Apr, 2027
(1 year, 11 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nexiclon Xr's drug page
3. Qdolo
Qdolo is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103452 | Tramadol hydrochloride solution |
01 Sep, 2040
(15 years from now)
| Active |
| US11752103 | Tramadol hydrochloride solution |
01 Sep, 2040
(15 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qdolo's drug page